Oncotarget

Corrections:

Correction: Acute myeloid leukemia with t(4;12)(q12;p13): an aggressive disease with frequent involvement of PDGFRA and ETV6

PDF  |  How to cite

Oncotarget. 2018; 9:34449-34449. https://doi.org/10.18632/oncotarget.26205

Metrics: PDF 609 views  |   ?  

Jingyi Li1,2,*, Jie Xu1,*, Lynne V. Abruzzo1,3, Guilin Tang1, Shaoying Li1, M. James You1, Gary Lu1,4, Elias J. Jabbour5, Qi Deng2, Carlos E. Bueso-Ramos1, L. Jeffrey Medeiros1 and C. Cameron Yin1

1 Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
2 Department of Hematology, Tianjin First Center Hospital, Tianjin, China
3 Current address: Department of Pathology, The Ohio State University, College of Medicine, Columbus, OH, USA
4 Current address: Department of Biomedical Sciences, University of South Carolina School of Medicine, Greenville, SC, USA
5 Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
* These authors contributed equally to this work

Published: September 28, 2018

This article has been corrected: The correct author affiliation is given below:

1 Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA

Original article: Oncotarget. 2018; 9:10987-10994. DOI: https://doi.org/10.18632/oncotarget.23743.


Creative Commons License All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 3.0 License.
PII: 26205